City Doctor’s Research Papers Accepted at EFORT Congress
Two research papers authored by Dr. Abdul D. Khan, a senior orthopaedic surgeon and Head of Department, have been accepted for presentation at the annual congress of the European Federation of National Associations of Orthopaedics and Traumatology (EFORT), which will take place in Malaga, Spain, this May.
EFORT is recognized as one of Europe’s leading forums for orthopaedic science, bringing together clinicians, researchers, and healthcare leaders to discuss advances in musculoskeletal care. Having two papers accepted for the same edition of the congress is a significant academic achievement.
One of Dr. Khan’s papers presents the two-year functional outcomes of Bone Marrow Aspirate Concentrate (BMAC) injections in patients with hip osteoarthritis. The study reports measurable improvements in pain reduction, joint function, and mobility. BMAC therapy utilizes concentrated cells derived from a patient’s own bone marrow to support tissue repair and regeneration. Dr. Khan introduced this procedure in the region as part of the hospital’s regenerative orthopaedic program.
The second paper details the 18-month functional follow-up results of Platelet-Rich Plasma (PRP) injections for degenerative meniscal lesions of the knee. PRP therapy involves isolating and concentrating platelets from the patient’s blood, which are then injected to promote healing, reduce inflammation, and improve symptoms. The findings indicate encouraging recovery trends among appropriately selected patients.
In an interview with The Coastal Times, Dr. Khan explained that both studies were designed to evaluate the medium-term effectiveness of regenerative orthopaedic interventions. “Our focus was on systematically tracking patient progress over extended follow-up periods. The data indicate meaningful functional improvement and symptom relief in carefully selected cases,” he stated.
Hospital representatives noted that patients enrolled in the studies reported satisfactory recovery and an improved quality of life. Many participants also expressed appreciation for access to advanced, minimally invasive treatment options that may delay or reduce the need for surgery.